Smith & Nephew (SNNUF) EBT Margin (2009 - 2024)
Smith & Nephew (SNNUF) reported EBT Margin of 8.95% for Q4 2024, up 14.06% quarter-over-quarter from 7.85% in Q4 2022.
Smith & Nephew (SNNUF) EBT Margin (2009 - 2024) Analysis & Trends
Smith & Nephew has reported EBT Margin for 15 years, with the latest figure at 8.95% in Q4 2024.
- For the quarter ending Q4 2024, EBT Margin changed N/A year-over-year to 8.95%; the trailing twelve-month figure through Dec 2024 stood at 8.86% (changed N/A YoY), and the FY2025 full-year result was 12.64%, up 407.0% from the prior year.
- EBT Margin for Q4 2024 stood at 8.95%, up from 7.85% in the prior quarter.
- The five-year high for EBT Margin was 8.95% in Q4 2024, with the low at 1.67% in Q4 2020.
- Historically, EBT Margin has averaged 5.93% across 4 years, with a median of 8.21% in 2022.
- Annual changes were most pronounced in 2020 — EBT Margin slumped 1708 bps — and 2021, when it soared 1025 bps.
- Smith & Nephew's EBT Margin stood at 1.67% in 2020, then surged by 614 bps to 8.58% in 2021, then slipped by 9 bps to 7.85% in 2022, then climbed by 14 bps to 8.95% in 2024.
- The last three EBT Margin figures came in at 8.95% (Q4 2024), 7.85% (Q4 2022), and 8.58% (Q4 2021), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 15.57% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 27.84% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4.87% |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 22.61% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 9.84% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 19.17% |
| 10 | Smith & Nephew | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 8.95% |
| Dec 31, 2022 | 7.85% |
| Dec 31, 2021 | 8.58% |
| Dec 31, 2020 | -1.67% |
| Dec 31, 2019 | 15.41% |
| Dec 31, 2018 | 13.98% |
| Dec 31, 2017 | 16.40% |
| Dec 31, 2016 | 14.05% |
| Dec 31, 2015 | 18.09% |
| Dec 31, 2014 | 46.26% |
| Sep 30, 2014 | 13.33% |
| Mar 31, 2014 | 16.97% |
| Dec 31, 2013 | 18.98% |
| Sep 28, 2013 | 17.53% |
| Jun 29, 2013 | 17.50% |
| Mar 31, 2013 | 19.74% |
| Dec 31, 2012 | 21.45% |
| Sep 29, 2012 | 19.64% |
| Jun 30, 2012 | 46.16% |
| Mar 31, 2012 | 19.78% |